Skip to main content
Erschienen in: Sleep and Breathing 4/2020

24.01.2020 | Sleep Breathing Physiology and Disorders • Original Article

Independent association of severity of obstructive sleep apnea with lipid metabolism of atherogenic index of plasma (AIP) and apoB/apoAI ratio

verfasst von: Bing Cao, Zeqin Fan, Yanhong Zhang, Taoping Li

Erschienen in: Sleep and Breathing | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Cardiovascular diseases (CVDs) are highly prevalent in obstructive sleep apnea (OSA), and dyslipidemia is an important factor. Atherogenic index of plasma (AIP, log[TG/HDL-C]) and apolipoproteinB to apolipoproteinAI ratio (apoB/apoAI ratio) are considered high quality predictors of cardiovascular risk. However, the associations between OSA severity and AIP and apoB/apoAI ratio remained unclear.

Methods

A retrospective study was performed in 284 patients. Subjects were assessed with polysomnography (PSG) test, and OSA severity was defined by AHI. Data collected included anthropometric measurements, medical history, sleep parameters, fasting plasma lipids, fasting blood glucose, and insulin.

Results

Participants were classified based on AHI into the following groups: control group (n = 28), mild group (n = 52), moderate group (n = 53), and severe group (n = 151). Triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), apoAI, AIP, apoB/apoAI ratio (low-density lipoprotein cholesterol), LDL-C/HDL-C ratio, and HDL-C/apoAI ratio showed statistical significance among AHI subgroups (P < 0.05). The Pearson correlation analysis revealed that AIP (r = 0.32, P < 0.001) and apoB/apoAI ratio (r = 0.24, P < 0.001) were positively related to AHI. By multivariate linear regression analysis, we found that AHI was independently related to AIP (β = 0.24, P = 0.001), apoB/apoAI ratio (β = 0.24, P<0.001).

Conclusion

AHI was independently correlated with AIP and apoB/apoAI ratio in OSA. Our findings suggested that AIP and apoB/apoAI ratio increased with OSA severity, which might be partly responsible for the high risk of CVDs in OSA.
Literatur
1.
Zurück zum Zitat Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRef Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRef
2.
Zurück zum Zitat Coughlin S (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741CrossRef Coughlin S (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741CrossRef
3.
Zurück zum Zitat Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. LANCET 364:937–952CrossRef Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. LANCET 364:937–952CrossRef
4.
Zurück zum Zitat Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF, Masana L, Mangas A, Hernandez-Mijares A, Gonzalez-Santos P, Ascaso JF, Pedro-Botet J (2009) Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 5:757–765PubMedPubMedCentral Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF, Masana L, Mangas A, Hernandez-Mijares A, Gonzalez-Santos P, Ascaso JF, Pedro-Botet J (2009) Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 5:757–765PubMedPubMedCentral
5.
Zurück zum Zitat Cai G, Shi G, Xue S, Lu W (2017) The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltimore) 96:e8058CrossRef Cai G, Shi G, Xue S, Lu W (2017) The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltimore) 96:e8058CrossRef
6.
Zurück zum Zitat Wu T, Gao Y, Zheng Y, Ma Y, Xie X (2018) (AIP-AI ) Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. LIPIDS HEALTH DIS 17:197 Wu T, Gao Y, Zheng Y, Ma Y, Xie X (2018) (AIP-AI ) Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. LIPIDS HEALTH DIS 17:197
7.
Zurück zum Zitat Kaneva AM, Potolitsyna NN, Bojko ER, Odland JØ (2015) The Apolipoprotein B/Apolipoprotein A-I ratio as a potential marker of plasma atherogenicity. Dis Markers 2015:1–7CrossRef Kaneva AM, Potolitsyna NN, Bojko ER, Odland JØ (2015) The Apolipoprotein B/Apolipoprotein A-I ratio as a potential marker of plasma atherogenicity. Dis Markers 2015:1–7CrossRef
8.
Zurück zum Zitat Dobiásová M, Frohlich J (2001) The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 34:583CrossRef Dobiásová M, Frohlich J (2001) The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 34:583CrossRef
9.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DIABETOLOGIA 28:412–419CrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DIABETOLOGIA 28:412–419CrossRef
10.
Zurück zum Zitat Roche F, Sforza E, Pichot V, Maudoux D, Garcin A, Celle S, Picard-Kossovsky M, Gaspoz J, Barthélémy JC (2009) Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 10:882–886CrossRef Roche F, Sforza E, Pichot V, Maudoux D, Garcin A, Celle S, Picard-Kossovsky M, Gaspoz J, Barthélémy JC (2009) Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 10:882–886CrossRef
11.
Zurück zum Zitat Nadeem R, Singh M, Nida M, Waheed I, Khan A, Ahmed S, Naseem J, Champeau D (2014) Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 10:475–489CrossRef Nadeem R, Singh M, Nida M, Waheed I, Khan A, Ahmed S, Naseem J, Champeau D (2014) Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 10:475–489CrossRef
12.
Zurück zum Zitat Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF (2001) (TG)relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154:50–59CrossRef Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF (2001) (TG)relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154:50–59CrossRef
13.
Zurück zum Zitat Adedayo AM, Olafiranye O, Smith D, Hill A, Zizi F, Brown C, Jean-Louis G (2014) Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath 18:13–18CrossRef Adedayo AM, Olafiranye O, Smith D, Hill A, Zizi F, Brown C, Jean-Louis G (2014) Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath 18:13–18CrossRef
14.
Zurück zum Zitat Kawano Y, Tamura A, Kadota J (2012) Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol. METABOLISM 61:186–192CrossRef Kawano Y, Tamura A, Kadota J (2012) Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol. METABOLISM 61:186–192CrossRef
15.
Zurück zum Zitat Marotta T, Ferrara LA, Di Marino L, Mancini M, Annuzzi G, Russo O, D’Orta G, Lucarelli C, Rossi F (1995) Factors affecting lipoprotein lipase in hypertensive patients. METABOLISM 44:712–718CrossRef Marotta T, Ferrara LA, Di Marino L, Mancini M, Annuzzi G, Russo O, D’Orta G, Lucarelli C, Rossi F (1995) Factors affecting lipoprotein lipase in hypertensive patients. METABOLISM 44:712–718CrossRef
16.
Zurück zum Zitat Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904CrossRef Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904CrossRef
17.
Zurück zum Zitat Zhan Y, Xu T, Tan X (2016) Two parameters reflect lipid-driven inflammatory state in acute coronary syndrome: atherogenic index of plasma, neutrophil-lymphocyte ratio. BMC Cardiovasc Disord 16:96CrossRef Zhan Y, Xu T, Tan X (2016) Two parameters reflect lipid-driven inflammatory state in acute coronary syndrome: atherogenic index of plasma, neutrophil-lymphocyte ratio. BMC Cardiovasc Disord 16:96CrossRef
18.
Zurück zum Zitat Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, Dadgarmoghaddam M (2015) Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran 29:240PubMedPubMedCentral Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, Dadgarmoghaddam M (2015) Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran 29:240PubMedPubMedCentral
19.
Zurück zum Zitat Wu TT, Gao Y, Zheng YY, Ma YT, Xie X (2018) Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis 17:197CrossRef Wu TT, Gao Y, Zheng YY, Ma YT, Xie X (2018) Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis 17:197CrossRef
20.
Zurück zum Zitat Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. LANCET 365:1046–1053CrossRef Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. LANCET 365:1046–1053CrossRef
21.
Zurück zum Zitat Walldius G, Jungner I (2004) Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 255:188–205CrossRef Walldius G, Jungner I (2004) Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 255:188–205CrossRef
22.
Zurück zum Zitat Walldius G, Jungner I (2006) The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. J Intern Med 259:493–519CrossRef Walldius G, Jungner I (2006) The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. J Intern Med 259:493–519CrossRef
23.
Zurück zum Zitat Xu H, Guan J, Yi H, Zou J, Meng L, Tang X, Zhu H, Yu D, Zhou H, Su K, Wang Y, Wang J, Yin S, Shanghai SHSR, The SSHS (2016) Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea: evidence from a large-scale cross-sectional study. Sleep Breath 20:627–634CrossRef Xu H, Guan J, Yi H, Zou J, Meng L, Tang X, Zhu H, Yu D, Zhou H, Su K, Wang Y, Wang J, Yin S, Shanghai SHSR, The SSHS (2016) Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea: evidence from a large-scale cross-sectional study. Sleep Breath 20:627–634CrossRef
24.
Zurück zum Zitat Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A, Hellenius ML, Fisher RM (2007) ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J 28:2637–2643CrossRef Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A, Hellenius ML, Fisher RM (2007) ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J 28:2637–2643CrossRef
25.
Zurück zum Zitat Sniderman AD, Faraj M (2007) Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome. Curr Opin Lipidol 18:633–637CrossRef Sniderman AD, Faraj M (2007) Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome. Curr Opin Lipidol 18:633–637CrossRef
26.
Zurück zum Zitat Seetho IW, Wilding JP (2014) Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome. ChroN Resp Dis 11:257–275CrossRef Seetho IW, Wilding JP (2014) Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome. ChroN Resp Dis 11:257–275CrossRef
27.
Zurück zum Zitat Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD (2004) The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355–1363CrossRef Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD (2004) The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355–1363CrossRef
28.
Zurück zum Zitat Rasouli M, Kiasari AM, Mokhberi V (2006) The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Clin Chem Lab Med (CCLM) 44 Rasouli M, Kiasari AM, Mokhberi V (2006) The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Clin Chem Lab Med (CCLM) 44
29.
Zurück zum Zitat Lin Q, Zhang X, Chen G, Huang D, Din H, Tang A (2012) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath 16:571–578CrossRef Lin Q, Zhang X, Chen G, Huang D, Din H, Tang A (2012) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath 16:571–578CrossRef
Metadaten
Titel
Independent association of severity of obstructive sleep apnea with lipid metabolism of atherogenic index of plasma (AIP) and apoB/apoAI ratio
verfasst von
Bing Cao
Zeqin Fan
Yanhong Zhang
Taoping Li
Publikationsdatum
24.01.2020
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 4/2020
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02016-1

Weitere Artikel der Ausgabe 4/2020

Sleep and Breathing 4/2020 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Original Article

Overlap syndrome: the coexistence of OSA further impairs cardiorespiratory fitness in COPD

Sleep Breathing Physiology and Disorders • Letter to the Editors (Invited)

Role of CD3+γδ-T cells in the association of obstructive sleep-disordered breathing and cancer

Sleep Breathing Physiology and Disorders • Review

Obstructive sleep apnea and cardiovascular disease, a story of confounders!

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.